Conference Coverage

ONS Annual Congress

2015    2014   2013   2012   2011



Additional Meeting Coverage


NCONN 2014

ONS Connections



Recent Conference Coverage

Transitioning High-Dose AML Chemo to Outpatient Setting Improves Quality of Life

Transitioning a long-standing intensive chemotherapy regimen for acute myeloid leukemia (AML) to the outpatient setting is safe and feasible.

Transdermal Granisetron May Be Appropriate for CINV Prevention in Lung Cancer

Granisetron transdermal system (GTS) may be appropriate for prevention of chemotherapy-induced nausea and vomiting (CINV) in lung cancer.

First Fully Integrated Oncology Emergency Department in the U.S. Launched

The James Cancer Hospital in Columbus, Ohio, has launched the first fully integrated oncology emergency department in the U.S.

Factors Affecting Women's Election to Undergo Bilateral Mastectomy Identified

Physicians and cancer survivors influence women undergoing bilateral mastectomy as their treatment for breast cancer.

Self-Management Handbook Useful for Patients with Limited English Proficiency

The feasibility for a self-management intervention handbook confirmed in Chinese American patients with cancer with limited English proficiency (LEP).

Previvorship: Managing Cancer Risk Decisions in Unaffected BRCA-positive Women

Four major themes characterize the experience of cancer risk management for women who are positive for BRCA genetic mutations.

Children's Oncology Group Examines National Educational Practices in Pediatric Patients

Premier study examines current delivery of patient/family education to pediatric patients with newly diagnosed cancer.

'Bathing and Honoring' Intervention Benefits Families After Acute Care Patient Death

Bathing and Honoring a patient who's died "provides a final positive experience for family members and allows them to begin the grieving process."

Behavioral Intervention Improves Sleep for Cancer Patient-Caregiver Dyads

A brief cognitive behavioral therapy for insomnia (CBT-I) improved sleep over 4 weeks with little to no negative effects on clinic flow.

New Instrument Assesses Caregiver Knowledge of Cancer Treatment Symptoms

Nursing Assessment of Family Caregiver Knowledge and Action Tool (NAFCKAT) may aid caregivers who need additional support.

Disparities persist in early stage breast cancer treatment

Despite its acceptance as standard of care neary 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), according to research presented at the ASCO 2014 Breast Cancer Symposium.

ASCO: Breathalyzer may help detect lung cancer

Researchers have developed a breathalyzer that can detect lung cancer and assess whether it is early or advanced, according to findings presented at the 2014 annual meeting of the American Society of Clinical Oncology.

ASCO: New treatment options available for advanced melanoma

New treatment options are available for advanced melanoma, according to three studies presented at the annual ASCO meeting.

pCR Not a surrogate for relapse-free survival in TNBC BRCA1/2 mutation carriers

In patients with triple-negative breast cancer (TNBC) who are BRCA1/2 mutation carriers, pathologic complete response (pCR) is not a surrogate for relapse-free survival, in contrast to those with non-BRCA mutations.

Does Early Integration of Palliative Care and Cancer Treatment Benefit Patients?

Immediately integrating cancer treatment and palliative care might improve survival at 1 year in patients with advanced cancers, suggest findings from the ENABLE III randomized controlled trial, presented at the 2014 ASCO Annual Meeting.

ASCO: Ramucirumab extends survival for NSC lung cancer

For patients with non-small-cell lung cancer who have relapsed after initial treatment, the addition of the anti-angiogenesis drug ramucirumab to standard docetaxel chemotherapy extends survival.

ASCO: New drug effective for metastatic prostate cancer

Enzalutamide, an oral androgen-receptor inhibitor, is superior to placebo for the treatment of metastatic prostate cancer before chemotherapy, according a study.

ASCO: Goserelin helps preserve ovarian function in early breast cancer

For premenopausal women with hormone receptor-negative early breast cancer treated with chemotherapy, goserelin can preserve ovarian function, according to a study presented at the annual ASCO meeting.

Early palliative support for family caregivers reduces depression

Family members caring for patients with advanced cancer benefit from early initiation of phone-based training and support.

Less frequent zoledronic acid for bone metastases safe, effective

In patients with breast cancer who had previously received monthly intravenous bisphosphonate therapy for bone metastases for a year or longer, maintenance zoledronic acid administered every 12 weeks was noninferior to every 4 weeks.

BRCA-targeting drug has benefit in prostate cancer

Trials results indicate that the pioneering drug olaparib, which targets inherited mutations, can be beneficial for men with prostate cancer.

Cancer detection rate in dense breast tissue dramatically improved with tomosynthesis

Digital breast tomosynthesis increases the rate of cancer detection in women with dense breast tissue by as much as 67%, according to research.

Active postdischarge intervention reduces ER visits and costs in major thoracic surgery

An active, postdischarge intervention after thoracic surgery resulted in numerous benefits, including shorter hospital stays and cost savings with no increase in adverse outcomes.

Triple-negative breast cancer is distinctly different in African American women

A new study reveals specific genetic alterations that appear to impact the prognosis and survival rates of African American women.

Most surgeons disregard US Preventive Services Task Force (USPSTF) breast screening recommendation

A majority of surgeon continue to recommend annual breast cancer screening for women in their forties, despite a 2009 US Preventive Services Task Force (USPSTF) recommendation that recommends otherwise.

Proton radiotherapy delivers more accurate cancer treatment with less collateral damage

Accurate administration of proton radiotherapy in mobile organs, such as the lung, can be difficult, but researchers have developed a model that will allow for better beam targeting.

'Neuroinvasion' May Impact Cancer Pain, Progression

Reciprocal relationship between cancer and neurons at play in tumor proliferation and pain sensitization.

Combined brachytherapy techniques should be benchmark for cervical cancer treatment

An investigation on the late side effects of a combination of two forms of brachytherapy to treat cervical cancer has revealed that the technique delivers higher radiation doses to the tumor without additional treatment-related complications afterwards.

Many women choose mastectomy, despite being eligible for breast-conserving therapy

Nearly a third of women eligible for breast-conserving therapy instead opt for removal of an entire breast.

Brachytherapy improves survival for inoperable early stage endometrial cancer

Brachytherapy, with or without external beam radiation, can improve survival in women with inoperable, early stage endometrial cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs